Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Recent & Breaking News (NYSEAM:ZOM)

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI

GlobeNewswire November 12, 2018

Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference

GlobeNewswire September 18, 2018

Zomedica Announces 2018 Annual Meeting Results

GlobeNewswire August 15, 2018

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results

GlobeNewswire August 9, 2018

Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares

GlobeNewswire June 28, 2018

Zomedica Joins Russell 3000™ and Russell Microcap® Indexes

GlobeNewswire June 25, 2018

Zomedica Provides Product Development Update

GlobeNewswire June 19, 2018

Zomedica Announces Changes to Commercialization Leadership Team

GlobeNewswire June 14, 2018

Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results

GlobeNewswire May 15, 2018

Zomedica Announces Up to $10 Million Private Offering of Common Shares

GlobeNewswire May 15, 2018

Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic

GlobeNewswire May 10, 2018

Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference

GlobeNewswire May 7, 2018

Zomedica to Present at 30th Annual ROTH Conference

GlobeNewswire March 7, 2018

Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results

GlobeNewswire February 28, 2018

Zomedica to participate in Merrill Lynch Animal Health Summit

Stockhouse Editorial February 20, 2018

Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit

GlobeNewswire February 20, 2018

Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

GlobeNewswire December 21, 2017

Zomedica Announces Achievement of Therapeutic Development Milestones

GlobeNewswire December 12, 2017

Zomedica commencing trading on NYSE American Exchange

Stockhouse Editorial November 21, 2017

Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission

GlobeNewswire November 20, 2017